MSVDX Mutual Fund

MSVDX Mutual Fund

NAV$6.54
See what you own twice
Check MSVDX against your other funds. Free for up to 5.
Check my overlap

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
0.95%
Dividend Yield (Current)
1.50%
Holdings
33
Inception Date
Dec 31, 2021
Fund Family
Morgan Stanley Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+1.22%
1 Year+29.47%
3 Year+3.22%

Asset Allocation

Stocks: 98.41%
Cash: 1.59%

Top Holdings

View All →
TickerNameWeight
ARGX:ASArgenx Se Sponsored Adr (1 Ads : 1 Ordinary)8.03%
LLYEli Lilly & Co.7.79%
ASND:COAscendis Pharma As Adr5.48%
NKTRNektar Therapeutics Class A4.75%
TMOThermo Fisherscientific Inc.4.28%
Top 10 Concentration: 49.11%Report Date: Mar 31, 2026
Download all 33 holdings for MSVDX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.50%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how MSVDX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

MSVDX Mutual Fund Overview

MSVDX Mutual Fund (Vitality Portfolio Class I) is managed by Morgan Stanley Investment Management. MSVDX expense ratio is 0.95%, holding 33 positions across sectors including Health Care, Information Technology. Inception date: 2021-12-31.

MSVDX performance shows a YTD return of 1.22%. The 1-year return is 29.47%. MSVDX dividend yield stands at 1.50%, paid annually.

MSVDX top holdings include Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) (8.0%), Eli Lilly & Co. (7.8%), Ascendis Pharma As Adr (5.5%), Nektar Therapeutics Class A (4.8%), Thermo Fisherscientific Inc. (4.3%). Go to all MSVDX holdings, MSVDX sectors, or MSVDX dividends.

MSVDX can be compared against other funds. Use MSVDX overlap to find shared positions, or MSVDX vs another fund for a side-by-side view. MSVDX alternatives are available via the screener, along with tax-loss harvesting opportunities.